Daily Headlinez Top News Updates
NEW DELHI: In what could be good news for patients, Indian Patent Office (IPO) has rejected MNC AbbVie’s patent application for its blockbuster cancer drug Venetoclax citing lack of inventive step. AbbVie markets the drug under the brand, Venclexta, in India. The company holds another patent on a composition of Venclexta, which is facing opposition…
NEW DELHI: Once relegated to the fringes of lifestyle care, obesity drugs have emerged as one of the world’s most powerful growth sectors, ranked by McKinsey alongside AI, EVs and robotics as trillion-dollar opportunities by 2040. In India, the surge in the weight-loss and metabolic therapy market is set to shape pharma’s growth narrative in…
NEW DELHI: The Indian Patent Office (IPO) has revoked the patent on Novartis’ cardiac blockbuster drug Vymada on grounds of lack of novelty, potentially paving the way for affordable generics to enter the market.The popular therapy has been in the spotlight for years, with generic versions from Natco, Torrent Pharma, MSN Labs and Eris Lifesciences…
